ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/03/28 | 1,048 | 1,062 | 1,027 | 1,035 | -3 | -0.3% | 595,600 |
2023/03/27 | 1,041 | 1,050 | 1,025 | 1,038 | -5 | -0.5% | 429,900 |
2023/03/24 | 1,060 | 1,062 | 1,043 | 1,043 | -20 | -1.9% | 423,900 |
2023/03/23 | 1,055 | 1,064 | 1,037 | 1,063 | -16 | -1.5% | 527,400 |
2023/03/22 | 1,090 | 1,109 | 1,071 | 1,079 | +5 | +0.5% | 577,900 |
2023/03/20 | 1,142 | 1,161 | 1,072 | 1,074 | -51 | -4.5% | 839,500 |
2023/03/17 | 1,050 | 1,138 | 1,049 | 1,125 | +73 | +6.9% | 985,200 |
2023/03/16 | 1,045 | 1,058 | 1,021 | 1,052 | -3 | -0.3% | 540,600 |
2023/03/15 | 1,049 | 1,075 | 1,045 | 1,055 | +8 | +0.8% | 481,100 |
2023/03/14 | 1,036 | 1,059 | 1,022 | 1,047 | +10 | +1% | 584,500 |
2023/03/13 | 1,036 | 1,041 | 1,013 | 1,037 | -24 | -2.3% | 852,900 |
2023/03/10 | 1,055 | 1,070 | 1,042 | 1,061 | +9 | +0.9% | 602,200 |
2023/03/09 | 1,027 | 1,055 | 1,020 | 1,052 | +20 | +1.9% | 451,900 |
2023/03/08 | 1,049 | 1,050 | 1,029 | 1,032 | -24 | -2.3% | 638,200 |
2023/03/07 | 1,060 | 1,068 | 1,047 | 1,056 | -9 | -0.8% | 387,100 |
2023/03/06 | 1,079 | 1,084 | 1,065 | 1,065 | -1 | -0.1% | 244,800 |
2023/03/03 | 1,061 | 1,083 | 1,058 | 1,066 | +3 | +0.3% | 305,200 |
2023/03/02 | 1,055 | 1,069 | 1,044 | 1,063 | +13 | +1.2% | 436,300 |
2023/03/01 | 1,087 | 1,089 | 1,042 | 1,050 | -28 | -2.6% | 689,800 |
2023/02/28 | 1,068 | 1,097 | 1,068 | 1,078 | +14 | +1.3% | 586,700 |
2023/02/27 | 1,079 | 1,088 | 1,056 | 1,064 | -33 | -3% | 720,300 |
2023/02/24 | 1,115 | 1,117 | 1,093 | 1,097 | -9 | -0.8% | 288,200 |
2023/02/22 | 1,111 | 1,121 | 1,094 | 1,106 | -34 | -3% | 518,400 |
2023/02/21 | 1,155 | 1,155 | 1,130 | 1,140 | -14 | -1.2% | 326,200 |
2023/02/20 | 1,097 | 1,154 | 1,096 | 1,154 | +57 | +5.2% | 560,900 |
2023/02/17 | 1,117 | 1,140 | 1,090 | 1,097 | -31 | -2.7% | 759,500 |
2023/02/16 | 1,165 | 1,165 | 1,085 | 1,128 | -34 | -2.9% | 1,750,600 |
2023/02/15 | 1,167 | 1,169 | 1,135 | 1,162 | -11 | -0.9% | 734,300 |
2023/02/14 | 1,168 | 1,184 | 1,162 | 1,173 | +4 | +0.3% | 369,300 |
2023/02/13 | 1,166 | 1,174 | 1,147 | 1,169 | -3 | -0.3% | 324,800 |
2023/02/10 | 1,196 | 1,206 | 1,165 | 1,172 | -34 | -2.8% | 597,400 |
2023/02/09 | 1,195 | 1,208 | 1,192 | 1,206 | -3 | -0.2% | 340,500 |
2023/02/08 | 1,197 | 1,209 | 1,188 | 1,209 | +1 | +0.1% | 257,600 |
2023/02/07 | 1,208 | 1,213 | 1,198 | 1,208 | +8 | +0.7% | 229,900 |
2023/02/06 | 1,225 | 1,229 | 1,196 | 1,200 | -27 | -2.2% | 447,000 |
2023/02/03 | 1,231 | 1,243 | 1,220 | 1,227 | +9 | +0.7% | 280,800 |
2023/02/02 | 1,232 | 1,242 | 1,215 | 1,218 | +7 | +0.6% | 379,200 |
2023/02/01 | 1,202 | 1,242 | 1,197 | 1,211 | +18 | +1.5% | 415,300 |
2023/01/31 | 1,179 | 1,198 | 1,173 | 1,193 | -2 | -0.2% | 285,800 |
2023/01/30 | 1,222 | 1,233 | 1,185 | 1,195 | -20 | -1.6% | 432,800 |
2023/01/27 | 1,221 | 1,226 | 1,199 | 1,215 | +1 | +0.1% | 357,000 |
2023/01/26 | 1,238 | 1,249 | 1,210 | 1,214 | -15 | -1.2% | 319,300 |
2023/01/25 | 1,229 | 1,238 | 1,214 | 1,229 | -3 | -0.2% | 284,000 |
2023/01/24 | 1,243 | 1,246 | 1,219 | 1,232 | +8 | +0.7% | 341,400 |
2023/01/23 | 1,208 | 1,243 | 1,207 | 1,224 | +29 | +2.4% | 542,300 |
2023/01/20 | 1,213 | 1,218 | 1,182 | 1,195 | -31 | -2.5% | 517,600 |
2023/01/19 | 1,172 | 1,236 | 1,164 | 1,226 | +42 | +3.5% | 842,100 |
2023/01/18 | 1,137 | 1,197 | 1,134 | 1,184 | +54 | +4.8% | 855,400 |
2023/01/17 | 1,180 | 1,211 | 1,130 | 1,130 | -49 | -4.2% | 991,400 |
2023/01/16 | 1,199 | 1,219 | 1,175 | 1,179 | -35 | -2.9% | 680,800 |
501~
550
件表示中 / 3678件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 180,700円 | +21.7% | +999.9% | 0.00% | 7.52倍 | 2.49倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 293,400円 | +3.0% | +27.5% | 2.73% | 18.57倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 141,700円 | +3.2% | +4.5% | 3.67% | 16.28倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 208,800円 | +0.4% | -8.4% | 2.54% | 26.80倍 | 1.52倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
クオリプス | 890,000円 | +660.9% | - | 0.00% | - | 12.91倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
市場注目の銘柄
チャート関連のコラム